521 related articles for article (PubMed ID: 29954406)
1. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer.
Huang X; Zhang H; Guo X; Zhu Z; Cai H; Kong X
J Hematol Oncol; 2018 Jun; 11(1):88. PubMed ID: 29954406
[TBL] [Abstract][Full Text] [Related]
2. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer.
Lederer M; Bley N; Schleifer C; Hüttelmaier S
Semin Cancer Biol; 2014 Dec; 29():3-12. PubMed ID: 25068994
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation
Wan BS; Cheng M; Zhang L
World J Gastroenterol; 2019 Oct; 25(40):6063-6076. PubMed ID: 31686763
[TBL] [Abstract][Full Text] [Related]
4. Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice.
Manieri NA; Drylewicz MR; Miyoshi H; Stappenbeck TS
Gastroenterology; 2012 Jul; 143(1):110-21.e10. PubMed ID: 22465430
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.
Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L
Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.
Müller S; Bley N; Glaß M; Busch B; Rousseau V; Misiak D; Fuchs T; Lederer M; Hüttelmaier S
Nucleic Acids Res; 2018 Jul; 46(12):6285-6303. PubMed ID: 29660014
[TBL] [Abstract][Full Text] [Related]
7. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Chen HM; Lin CC; Chen WS; Jiang JK; Yang SH; Chang SC; Ho CL; Yang CC; Huang SC; Chao Y; Liao TT; Hwang WL; Teng HW
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203267
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.
Ding N; Cao G; Wang Z; Xu S; Chen W
Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.
Gutschner T; Hämmerle M; Pazaitis N; Bley N; Fiskin E; Uckelmann H; Heim A; Groβ M; Hofmann N; Geffers R; Skawran B; Longerich T; Breuhahn K; Schirmacher P; Mühleck B; Hüttelmaier S; Diederichs S
Hepatology; 2014 May; 59(5):1900-11. PubMed ID: 24395596
[TBL] [Abstract][Full Text] [Related]
10. The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.
Müller S; Bley N; Busch B; Glaß M; Lederer M; Misiak C; Fuchs T; Wedler A; Haase J; Bertoldo JB; Michl P; Hüttelmaier S
Nucleic Acids Res; 2020 Sep; 48(15):8576-8590. PubMed ID: 32761127
[TBL] [Abstract][Full Text] [Related]
11. Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAF
Kim T; Havighurst T; Kim K; Albertini M; Xu YG; Spiegelman VS
Mol Carcinog; 2018 May; 57(5):678-683. PubMed ID: 29369405
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.
Habashy DA; Hamad MHM; Ragheb M; Khalil ZA; El Sobky SA; Hosny KA; Esmat G; El-Ekiaby N; Fawzy IO; Abdelaziz AI
Life Sci; 2022 Dec; 310():121075. PubMed ID: 36243115
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP1 over-expression in skin squamous cell carcinoma cells is essential for cell growth.
Liu Z; Wu G; Lin C; Guo H; Xu J; Zhao T
Biochem Biophys Res Commun; 2018 Jun; 501(3):731-738. PubMed ID: 29753746
[TBL] [Abstract][Full Text] [Related]
14. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
[No Abstract] [Full Text] [Related]
15. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.
Elcheva IA; Gowda CP; Bogush D; Gornostaeva S; Fakhardo A; Sheth N; Kokolus KM; Sharma A; Dovat S; Uzun Y; Schell TD; Spiegelman VS
Front Immunol; 2023; 14():1224516. PubMed ID: 37503349
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
Huang S; Wu Z; Cheng Y; Wei W; Hao L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):743-752. PubMed ID: 31089713
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1).
Hämmerle M; Gutschner T; Uckelmann H; Ozgur S; Fiskin E; Gross M; Skawran B; Geffers R; Longerich T; Breuhahn K; Schirmacher P; Stoecklin G; Diederichs S
Hepatology; 2013 Nov; 58(5):1703-12. PubMed ID: 23728852
[TBL] [Abstract][Full Text] [Related]
18. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.
Ohdaira H; Sekiguchi M; Miyata K; Yoshida K
Cell Prolif; 2012 Feb; 45(1):32-8. PubMed ID: 22151897
[TBL] [Abstract][Full Text] [Related]
20. Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.
Wang L; Aireti A; Aihaiti A; Li K
Pathol Oncol Res; 2019 Apr; 25(2):527-533. PubMed ID: 30220021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
